CGS-19755
CGS-19755[edit | edit source]
CGS-19755 is a potent and selective antagonist of the NMDA receptor, a type of glutamate receptor in the brain. It has been studied for its potential therapeutic effects in various neurological conditions.
Chemical Structure and Properties[edit | edit source]
CGS-19755, also known as Selfotel, is a competitive antagonist at the NMDA receptor. Its chemical structure is characterized by the presence of a quinoxalinedione moiety, which is crucial for its activity at the receptor site.
Mechanism of Action[edit | edit source]
CGS-19755 acts by binding to the NMDA receptor at the glutamate binding site, thereby inhibiting the action of glutamate, the primary excitatory neurotransmitter in the central nervous system. This inhibition can protect neurons from excitotoxicity, which is a pathological process that can lead to neuronal death in conditions such as stroke and traumatic brain injury.
Therapeutic Potential[edit | edit source]
The potential therapeutic applications of CGS-19755 have been explored in several neurological disorders:
- Stroke: By preventing excitotoxicity, CGS-19755 may reduce the extent of brain damage following an ischemic stroke.
- Traumatic Brain Injury (TBI): Similar to its effects in stroke, CGS-19755 may help in reducing neuronal damage following TBI.
- Epilepsy: As an NMDA receptor antagonist, CGS-19755 may have anticonvulsant properties, although its clinical use in epilepsy is not well established.
Clinical Trials and Research[edit | edit source]
Despite its promising mechanism of action, clinical trials with CGS-19755 have faced challenges. Some studies have reported adverse effects, such as neurotoxicity and psychotomimetic effects, which have limited its development as a therapeutic agent.
Safety and Side Effects[edit | edit source]
The use of CGS-19755 has been associated with several side effects, including:
- Neurotoxicity: High doses or prolonged use can lead to neuronal damage.
- Psychotomimetic effects: Some patients may experience symptoms similar to those seen in psychosis.
Conclusion[edit | edit source]
While CGS-19755 has shown potential in preclinical studies, its clinical application has been limited by safety concerns. Ongoing research is needed to better understand its pharmacological profile and to develop safer NMDA receptor antagonists.
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
